January, 2026

Significant Refundable R&D Offsets receipts reported to the ASX in recent months to January 2026

January 19th, 2026

Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $5.34 M related to its anti-infective platform; Race Oncology (ASX:RAC) received $2.8M related to its cancer treatments; Ecograf (ASX: EGR) received $1.7M related to its EcoGraf HFfree proprietary purification technology; Chimeric Therapeutics (ASX: CHM)  received $4.5M related to its cancer treatments; Elixir Energy (ASX: EXR) received $3.8M related to its unconventional gas project […]

Read More

R&D Tax Incentive – Potential Key Events in 2026

January 7th, 2026

Some key events impacting Australia’s R&D Tax Incentive over the past 12 months during calendar year 2025 included: The release of proposed legislation to exclude gambling and tobacco companies from eligibility under the R&D Tax Incentive; The strategic examination and review of Australia’s Research and Development (R&D) system progressed and released a discussion paper on R&D Incentives that contained some significant potential changes for consideration. Swanson Reed made a submission to both the general review and the discussion paper on R&D Incentives; A new R&D Tax Incentive registration […]

Read More

DroneShield Ltd has used Australia’s refundable R&D Tax Offset to become Australian Success Story

September 3rd, 2025

One of the best performing stocks on the ASX over the past few years has been Sydney based DroneShield Ltd which has seen the stock price rise from approximately $0.20 in September 2022 to $3.20 in September 2025. DroneShield Ltd has become a world-leading Australian developer of AI-powered counter-drone and electronic warfare solutions, and has recently announced a number of substantial contracts with international governments amid an environment of increased government expenditure on defence. In addition to its warfare solutions, […]

Read More

Robyn Denholm comments on R&D Spending Gap

June 9th, 2025

In recent comments published by The Australian, Robyn Denholm, the Australian-based Tesla chair, has expressed concerns over slowing business investment in Australia, noting that “Australia is not living up to its full potential” in terms of investment and R&D She highlighted that Australia’s combined government and business spending on R&D has fallen to 1.68% of GDP since 2008, compared to the OECD average of 2.73%. This R&D spending gap equates to approximately $25 billion per year.  “We need to see […]

Read More

Categories

Archives